The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFS.L Regulatory News (AFS)

  • There is currently no data for AFS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of EGM and Director Appointments

26 Mar 2021 07:00

RNS Number : 5650T
Amiad Water Systems Ltd
26 March 2021
 

26 March 2021

 

Amiad Water Systems Ltd.

("Amiad" or the "Company")

  

Notice of EGM and Director Appointments

 

Amiad (AIM: AFS), a leading global producer of water treatment and filtration solutions, announces the proposed appointment of Ms Ronit Fein and Ms Avital Refaely as statutory external directors of the Company.

 

The appointment of new statutory external directors and certain associated matters are required to be approved by a requisite majority of shareholders at an Extraordinary General Meeting ("EGM") of the Company. The EGM to approve the new directors' appointments, among other resolutions, is to be held at 9.00am BST on 6 May 2021 at the offices of Bryan Cave Leighton Paisner LLP, Governor's House, 5 Laurence Pountney Hill, London, EC4R 0BR.

 

In light of the current circumstances of the ongoing COVID-19 pandemic and government restrictions, the Board of Directors has arranged for the quorum of one shareholder present in person or by proxy holding, in aggregate, at least 25% of the voting rights in the Company to be physically present at the EGM and no other shareholders will be allowed to attend in person. To have their votes counted, all shareholders are urged to appoint the Chairman of the meeting as their proxy and holders of depository interests are urged to instruct Link Market Services Trustees to vote on their behalf.

 

Further information, including details on the EGM and the resolutions to be proposed at the EGM, can be found in the circular containing the Notice of EGM that, today, has been made available to shareholders of the Company as an electronic communication and published on Amiad's website at: https://amiad.com/list-circulars/ 

 

Proposed Director Appointments

 

Ms Ronit Fein, aged 49, has over 25 years' corporate and financial experience. She is currently CFO of Ahava Dead Sea Laboratories Ltd, an international cosmetics company that is based in Israel and with a global distribution network. Other positions have included Chief Economist at Keter Group, a manufacturer and marketer of resin-based household and garden consumer products that is valued at over $1bn. During her nine years at Keter Group, she was involved in M&A transactions and in developing business strategy, as well as in overseeing the turnaround of newly-acquired subsidiary companies. Ms Fein also served as a member of the Board of Directors of TASE-listed Hamat Group Ltd (formerly Merhav Ceramic and Building Materials Center Ltd).

 

Ms Avital Refaely (neé Treister), aged 51, has over 25 years' experience in business and marketing. She is currently VP Market Development, International Markets, for K Health, a primary care provider via a data-driven healthcare app, which in December 2020 raised $132m valuing the company at $1.5bn. Prior to joining K Health, she spent over 10 years as VP Marketing for the Ofer Malls of TASE-listed Melisron Group, a real estate development company and one of the largest operators of shopping centres in Israel. Other previous roles include CEO of Max Brenner, a chocolate restaurant and retail brand, where she oversaw the global expansion of the business, including the opening of its first location in the US in New York City.

 

Ms Fein and Ms Refaely will serve as statutory external directors of the Company, as required under Israeli Companies Law, for a three-year period commencing from the conclusion of the EGM.

 

 

Pursuant to Schedule 2(g) of the AIM Rules for Companies, Ronit Fein (aged 49) and Avital Refaely (aged 51) have held the following directorships or partnerships in the past five years:

 

Ms Ronit Fein

Current Directorships

Directorships within the last five years

N/A

N/A

 

 

Ms Avital Refaely

Current Directorships

Directorships within the last five years

N/A

British Israel Investments Ltd

 

Ronit Fein and Avital Refaely do not currently hold any shares in the Company.

 

There is no further information to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

 

Enquiries

 

Amiad Water Systems Ltd.

 

Dori Ivzori, Chief Executive Officer

Relly Shimko, Chief Financial Officer

+972 4 690 9500

 

Stifel Nicolaus Europe Ltd.

 

Fred Walsh, Stewart Wallace

+44 20 7710 7600

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

 

About Amiad

 

Amiad Water Systems (AIM: AFS) is a leading global producer of automatic, self-cleaning water treatment and filtration products and systems. Through its engineering skills and ability to innovate, Amiad provides cost-effective "green" solutions for irrigation and industrial purposes. In these markets, its unique and high-quality products are being integrated into the core of systems for filtration and water treatment, micro irrigation and membrane protection, wastewater and potable water treatment, cooling systems and sea water filtration. Headquartered in Israel, Amiad provides these solutions through ten subsidiaries and a comprehensive network of distributors to customers in more than 80 countries.

 

FIMI Opportunity Funds, the leading private equity investor in Israel, is a controlling shareholder of Amiad, with an interest in 39.5% of the Company's outstanding issued share capital.

 

For additional information or product details, please visit www.amiad.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUQPWUPGGBA
Date   Source Headline
25th Mar 20204:43 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 202010:34 amRNSFurther update on EGM
20th Mar 20207:00 amRNSUpdate on EGM
4th Mar 20207:00 amRNSProposed Directorate Change
27th Feb 20207:00 amRNSUpdate on potential investment and Notice of EGM
11th Feb 20207:00 amRNSAmiad receives Green Economy Mark
2nd Jan 20204:25 pmRNSPDMR Exercise of Options, Issue of Equity and TVR
13th Dec 20197:00 amRNSTrading Update
12th Dec 201912:12 pmRNSResult of AGM
22nd Nov 20197:00 amRNSUpdate on Potential Investment
7th Nov 201912:50 pmRNSNotice of AGM, Options Grant & Directorate Change
11th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSUpdate on Potential Investment
2nd Sep 20198:54 amRNSResponse to Media Speculation
28th May 20197:00 amRNSPublication of Annual Report and Accounts
21st May 20197:00 amRNSDirectorate Change
7th May 20194:40 pmRNSSecond Price Monitoring Extn
7th May 20194:35 pmRNSPrice Monitoring Extension
7th May 201910:20 amRNSHolding(s) in Company
7th May 201910:20 amRNSHolding(s) in Company
28th Mar 20197:00 amRNSFinal Results
19th Mar 20197:00 amRNSAppointment of Chief Financial Officer
13th Nov 20187:00 amRNSManagement Change
6th Nov 20185:13 pmRNSSecond Price Monitoring Extn
6th Nov 20184:35 pmRNSPrice Monitoring Extension
13th Sep 201812:01 pmRNSResult of AGM and Director Appointment
5th Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSAmiad supplies major Singapore desalination plant
2nd Aug 20183:00 pmRNSNotice of AGM and Directorate Change
26th Jul 20183:48 pmRNSHolding(s) in Company
24th Jul 20182:05 pmRNSSecond Price Monitoring Extn
24th Jul 20182:00 pmRNSPrice Monitoring Extension
24th Jul 20187:00 amRNSAcquisition of Amiad India
23rd Jul 201812:38 pmRNSHolding(s) in Company
13th Jun 20184:44 pmRNSDeath of a Director
25th May 20189:00 amRNSPublication of Annual Report and Accounts
11th Apr 20187:00 amRNSFinal Results
3rd Apr 20187:00 amRNSDirectorate Change
28th Feb 201811:50 amRNSResult of EGM and Director Appointment
24th Jan 20183:30 pmRNSNotice of EGM and Directorate Change
22nd Nov 20172:55 pmRNSLicensing agreement with Dow Global Technologies
6th Sep 20177:00 amRNSInterim Results
3rd Aug 201711:37 amRNSResult of AGM
12th Jul 20177:00 amRNSUpdate regarding French certification
28th Jun 20178:30 amRNSNotice of AGM
31st May 20177:00 amRNSNotification regarding French certification
28th Apr 201711:51 amRNSPublication of Annual Report
30th Mar 20177:00 amRNSFinal Results
28th Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.